PlacEntal Acute Atherosis RefLecting Subclinical Atherosclerosis
Recruiting · NCT05500989 · Observational (researchers observe without assigning treatment) · Lead sponsor: Maastricht University Medical Center
View the official record on ClinicalTrials.gov →What this trial is about
Pregnancy is considered a cardiovascular (CV) stress test, and complicated pregnancies are associated with an increased risk for cardiovascular disease (CVD) later in life. Moreover, it is known that often the pregnancy induced CV adaptation does not resolve completely after a short postpartum (PP) period and it is not clear whether these induced changes will resolve over a longer period of time (i.e. in the upcoming months/years after delivery). Understanding the cardiac adaptation during pregnancy and the reversal process in the postpartum period, as well as the factors that influence this these processes, may provide us not only insight in this mechanism, but may help us in identifying factors that may be target points for modification.
Who can take part
Inclusion criteria
- Women aged ≥ 18 years
- Controls: Women with an uncomplicated pregnancy at the moment of inclusion (i.e no foetal or maternal placental complications, such as pregnancy induced hypertension, preeclampsia or HELLP-syndrome, or small for gestational birth infancies)
- Cases: Women diagnosed with a preeclamptic pregnancy at the moment of inclusion
Exclusion criteria
- Women who do not want to be informed about the results of the tests, or women who do not want their general practitioner and specialist(s) to be informed about the test results
- Allergy or intolerance to glyceryl trinitrate, betablockers or iodinated contrast media.
- Controls: Pre-existing chronic hypertension treated with antihypertensive medication or autoimmune disorder.
Where it is running
1 location listed.
- Maastricht University Medical Center (MUMC+) - Maastricht, Netherlands